Breast Cancer Research and Treatment
Overview
Breast Cancer Research and Treatment is a renowned scientific journal dedicated to advancing knowledge and understanding of breast cancer. It publishes cutting-edge research articles, reviews, and clinical studies that explore various aspects of breast cancer, including prevention, diagnosis, treatment, and survivorship. With a multidisciplinary approach, this journal serves as a valuable resource for researchers, clinicians, and healthcare professionals striving to improve outcomes and quality of life for individuals affected by breast cancer.
Details
Details
Abbr.
Breast Cancer Res Treat
Start
1981
End
Continuing
Frequency
Eighteen no. a year
p-ISSN
0167-6806
e-ISSN
1573-7217
Country
Netherlands
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 975
177
SJR / Ranks: 2588
1267
CiteScore / Ranks: 2534
7.50
JIF / Ranks: 2461
3.8
Recent Articles
1.
Wockel A, Park-Simon T, Korfel A, Raab K, Tesch H
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40087230
No abstract available.
2.
Xie L, Liu Y, Yang Y, Wang J, Zhang Y, Wang T, et al.
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40085414
Purpose: To evaluate the role of Postoperative Radiotherapy (PORT) in HER2-positive metastatic breast cancer (MBC) in the context of targeted therapy and clarify the subgroups that may benefit from PORT....
3.
Ghorbani M, Namazi S, Dehghani M, Razi F, Khalvati B, Dehshahri A
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40080356
Purpose: Recent studies have shown that the truncated isoform of the neurokinin-1 receptor (NK-1R) and its ligand, substance P (SP), are overexpressed in tumor cells playing a crucial role in...
4.
Basmadjian R, Xu Y, Quan M, Lupichuk S, Cheung W, Brenner D
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40072699
Introduction: Outcome prediction research in early-onset breast cancer (EoBC) is limited. This study evaluated the predictive performance of NHS PREDICT v2.1 and developed two prediction models for 5-year and 10-year...
5.
De Vis J, Wang C, Nguyen K, Sun L, Jia B, Sherry A, et al.
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40067427
Background: Triple-negative breast cancer (TNBC) patients are at increased risk for recurrence compared to other subtypes of breast cancer. Previous evidence showed that adiposity may contribute to worsened cancer control....
6.
Bellini A, Keegan T, Li Q, Jacinto A, Maguire F, Lyo V, et al.
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40064792
Purpose: Underweight women and those with obesity, defined as having a body mass index (BMI) ≥ 30 kg/m, diagnosed with breast cancer (BC) are known to have worse prognosis. Whether...
7.
Zhan H, Antony V, Tang H, Theriot J, Liang Y, Hui P, et al.
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40063317
Purpose: Hormone receptor (HR) status may be unstable during breast cancer (BC) progression, and changes occur in approximately 20-30% of BC patients at the time of recurrence. The biologic tumor...
8.
Li L, Zhang Z, Huang N, Ren J, Qin Y, Luo Y
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40055251
Purpose: Forkhead box P3 (FOXP3), a key marker of regulatory T cells (Tregs), is crucial for Treg differentiation and development. Emerging evidence suggests that FOXP3 is also expressed in various...
9.
Nakauchi C, Masunaga N, Kagara N, Oshiro C, Shimoda M, Shimazu K
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40055250
Purpose: The detection of circulating tumor DNA (ctDNA) is a valuable method to predict the risk of recurrence and to detect real-time gene changes. The amount of ctDNA is affected...
10.
Zhang C, Liu J, Gu T, Meng X, Cai X, Zhang J, et al.
Breast Cancer Res Treat
. 2025 Mar;
PMID: 40050525
Purpose: Combination therapy has emerged as a leading trend in cancer treatment, having had a significant impact on the management of advanced-stage breast cancer. This approach, which relies on immune...